Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hematologic tumors].

Makoto Ogawa1

  • 1Nagoya Kyoritu Hospital, 1-172 Hokke, Nakagawa-ku, Nagoya 454-0933, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 31, 2003
PubMed
Summary
This summary is machine-generated.

Cytarabine and daunorubicin enable acute myeloid leukemia (AML) cures. Chemotherapy regimens like idarubicin plus cytarabine, ATRA for acute promyelocytic leukemia, ABVD for Hodgkin's lymphoma, and CHOP for non-Hodgkin's lymphoma are standard treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self- and observer-rated functioning and psychiatric readmission: findings from multicenter longitudinal data.

Scientific reports·2026
Same author

Contribution of Fundamental Frequency to Perceived Vocal Roughness: Evidence From Time-Scaled Natural Voice Samples.

Journal of voice : official journal of the Voice Foundation·2026
Same author

Psychoacoustically guided midfrequency band-limiting improves the diagnostic utility of classical acoustic measures in dysphonia.

Scientific reports·2026
Same author

Exposure-based cognitive behavioral therapy delivered by assertive community treatment teams for severe mental illness with symptoms of anxiety: a cluster randomized controlled trial.

Psychological medicine·2026
Same author

Longitudinal impact of the coronavirus disease pandemic on pediatric adenoidectomy volume and referrals in Japan: A 6-year retrospective study.

International journal of pediatric otorhinolaryngology·2025
Same author

Silica Nanolayer on Functional Particles: Structural Variation for the Functional Design.

Langmuir : the ACS journal of surfaces and colloids·2025
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Hematology and Oncology
  • Clinical Pharmacology

Context:

  • Chemotherapy regimens have significantly advanced the treatment of hematologic malignancies.
  • Established protocols guide the first-line treatment for various subtypes of leukemia and lymphoma.

Purpose:

  • To review the development and current application of key chemotherapeutic agents in hematologic cancers.
  • To highlight the efficacy of specific treatment combinations for acute myeloid leukemia (AML), Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Summary:

  • Cytarabine and daunorubicin have been pivotal in achieving cures for AML.
  • Current AML treatment often involves idarubicin and cytarabine; ATRA has improved outcomes for acute promyelocytic leukemia.
  • First-line chemotherapy for advanced Hodgkin's lymphoma is ABVD, while CHOP is frequently used for advanced non-Hodgkin's lymphoma.

Related Experiment Videos

Impact:

  • These chemotherapeutic advancements have drastically improved survival rates and cure possibilities for patients with leukemia and lymphoma.
  • Standardized treatment protocols ensure consistent and effective care, based on robust clinical trial data.